We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-8.36%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$74.3B
AUM Growth
-$8.62B
(-10%)
Cap. Flow
-$532M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
52.32%
Holding
784
New
89
Increased
180
Reduced
401
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$556M |
| 2 |
NVIDIA
NVDA
|
+$117M |
| 3 |
Oracle
ORCL
|
+$104M |
| 4 |
Amazon
AMZN
|
+$79.8M |
| 5 |
Expedia Group
EXPE
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$161M |
| 2 |
Parker-Hannifin
PH
|
+$138M |
| 3 |
Cummins
CMI
|
+$94.8M |
| 4 |
Mettler-Toledo International
MTD
|
+$82.8M |
| 5 |
Home Depot
HD
|
+$77.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.44% |
| 2 | Communication Services | 20.45% |
| 3 | Consumer Discretionary | 17.53% |
| 4 | Healthcare | 11.66% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Emcor
EME
$35.7B
| $17.7K | ﹤0.01% |
+24
| New | +$17.5K |
|
652
Albemarle
ALB
$13.9B
| $17.6K | ﹤0.01% |
+98
| New | +$16.7K |
|
653
Synopsys
SNPS
$71.3B
| $17K | ﹤0.01% |
43
-17
| -28% | -$7.68K |
|
654
Huntington Ingalls Industries
HII
$12.6B
| $16.7K | ﹤0.01% |
+44
| New | +$18.1K |
|
655
Teradyne
TER
$57.2B
| $16.6K | ﹤0.01% |
+56
| New | +$15.6K |
|
656
TE Connectivity
TEL
$59.9B
| $16.5K | ﹤0.01% |
+79
| New | +$17.4K |
|
657
Freeport-McMoran
FCX
$91.2B
| $16.3K | ﹤0.01% |
+277
| New | +$16.7K |
|
658
Corning
GLW
$116B
| $16.2K | ﹤0.01% |
+119
| New | +$14.4K |
|
659
Constellation Energy
CEG
$94.1B
| $15.6K | ﹤0.01% |
56
-23
| -29% | -$6.99K |
|
660
Dollar General
DG
$28.1B
| $14.7K | ﹤0.01% |
+124
| New | +$17.7K |
|
|
MOMO
661
Hello Group
MOMO
$886M
| $14.7K | ﹤0.01% |
2,548
-3,752
| -60% | -$24.3K |
|
662
Tenet Healthcare
THC
$21.8B
| $14.5K | ﹤0.01% |
77
-434
| -85% | -$91.4K |
|
663
Unilever
UL
$141B
| $12.7K | ﹤0.01% |
223
-24
| -10% | -$1.61K |
|
664
Zoetis
ZTS
$31.9B
| $12.4K | ﹤0.01% |
105
-42
| -29% | -$5.19K |
|
665
Boston Scientific
BSX
$68.4B
| $12.2K | ﹤0.01% |
194
-434
| -69% | -$34.7K |
|
666
Atour Lifestyle Holdings
ATAT
$4.66B
| $12.1K | ﹤0.01% |
328
-772
| -70% | -$29.1K |
|
667
Capital One
COF
$129B
| $9.85K | ﹤0.01% |
54
-151
| -74% | -$31.6K |
|
668
China Yuchai International
CYD
$1.81B
| $9.28K | ﹤0.01% |
241
-359
| -60% | -$16K |
|
669
Vanguard Morningstar Small-Cap ETF
VB
$79.6B
| $9.17K | ﹤0.01% |
35
+34
| +3,400% | +$9.2K |
|
|
MRSH
670
Marsh
MRSH
$91.4B
| $6.59K | ﹤0.01% |
38
-164
| -81% | -$29.5K |
|
671
General Mills
GIS
$19.4B
| $4.09K | ﹤0.01% |
110
-2,619
| -96% | -$114K |
|
672
UiPath
PATH
$6.41B
| $2.19K | ﹤0.01% |
197
-2,618
| -93% | -$33.3K |
|
|
GRAL
673
GRAIL Inc
GRAL
$3.05B
| $293 | ﹤0.01% |
6
-31
| -84% | -$2.4K |
|
674
L3Harris
LHX
$50.7B
| – | – |
0
| – | – |
|
675
Shell
SHEL
$250B
| $82 | ﹤0.01% |
1
| – | – |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2026 Portfolio in Review
As of Q1 2026, Loomis, Sayles & Company held 784 positions worth $74.3B, down 10% from $83B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Loomis, Sayles & Company's Q1 2026 filing shows 89 new, 180 increased, 401 reduced and 66 closed positions. Its largest new stake was PTC Therapeutics: 493,603 shares worth $33.6M. The largest sale was Illumina, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Loomis, Sayles & Company's largest Q1 2026 buy was PTC Therapeutics: 493,603 shares worth $33.6M.
- Loomis, Sayles & Company added most to Booking.com in Q1 2026, an estimated $556M increase.
- Loomis, Sayles & Company's biggest Q1 2026 reduction was Illumina, cutting an estimated $161M.
- Loomis, Sayles & Company fully exited Wave Life Sciences in Q1 2026, selling an estimated $34.7M.
- Loomis, Sayles & Company's ten largest holdings make up 52% of its $74.3B portfolio in Q1 2026.
- Loomis, Sayles & Company opened 89 new positions and closed 66 in Q1 2026.
- Loomis, Sayles & Company's portfolio value fell 10% quarter-over-quarter to $74.3B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.